Literature DB >> 19086916

Using surveillance to evaluate influenza vaccine effectiveness.

Lisa A Jackson.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19086916     DOI： 10.1086/595863

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  7 in total

1.  Suppression of influenza A virus replication in human lung epithelial cells by noncytotoxic concentrations bafilomycin A1.

Authors:  Behzad Yeganeh; Saeid Ghavami; Andrea L Kroeker; Thomas H Mahood; Gerald L Stelmack; Thomas Klonisch; Kevin M Coombs; Andrew J Halayko
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-10-31       Impact factor: 5.464

Review 2.  Safety, efficacy, and immunogenicity of Flublok in the prevention of seasonal influenza in adults.

Authors:  Manon M J Cox; Ruvim Izikson; Penny Post; Lisa Dunkle
Journal:  Ther Adv Vaccines       Date:  2015-07

Review 3.  Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic review.

Authors:  Sheena G Sullivan; Shuo Feng; Benjamin J Cowling
Journal:  Expert Rev Vaccines       Date:  2014-10-28       Impact factor: 5.217

4.  Effects of different adjuvants in the context of intramuscular and intranasal routes on humoral and cellular immune responses induced by detergent-split A/H3N2 influenza vaccines in mice.

Authors:  Mariana Baz; Mukesh Samant; Hakima Zekki; Pascale Tribout-Jover; Martin Plante; Anne-Marie Lanteigne; Marie-Eve Hamelin; Corey Mallett; Barbara Papadopoulou; Guy Boivin
Journal:  Clin Vaccine Immunol       Date:  2011-12-21

5.  Neonatal outcomes after influenza immunization during pregnancy: a randomized controlled trial.

Authors:  Mark C Steinhoff; Saad B Omer; Eliza Roy; Shams El Arifeen; Rubhana Raqib; Caitlin Dodd; Robert F Breiman; K Zaman
Journal:  CMAJ       Date:  2012-02-21       Impact factor: 8.262

6.  Refining the approach to vaccines against influenza A viruses with pandemic potential.

Authors:  Rita Czako; Kanta Subbarao
Journal:  Future Virol       Date:  2015       Impact factor: 1.831

7.  Both hemispheric influenza vaccine recommendations would have missed near half of the circulating viruses in Madagascar.

Authors:  Julia Guillebaud; Jean-Michel Héraud; Norosoa H Razanajatovo; Alicia A Livinski; Wladimir J Alonso
Journal:  Influenza Other Respir Viruses       Date:  2017-11       Impact factor: 4.380
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.